These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 24595077)
1. Heterogeneous nuclear ribonucleoprotein U-like 1 and Poly (ADP-ribose) polymerase 1 are downregulated in renal cell carcinoma and connected with the prognosis. Xu T; Zou Q; Wu J; Yu B; Xu Z; Cai H; Zhang W Cancer Biomark; 2013 Jan; 13(6):411-5. PubMed ID: 24595077 [TBL] [Abstract][Full Text] [Related]
2. The role of hnRPUL1 involved in DNA damage response is related to PARP1. Hong Z; Jiang J; Ma J; Dai S; Xu T; Li H; Yasui A PLoS One; 2013; 8(4):e60208. PubMed ID: 23577092 [TBL] [Abstract][Full Text] [Related]
3. Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma. da Costa WH; Rezende M; Carneiro FC; Rocha RM; da Cunha IW; Carraro DM; Guimaraes GC; de Cassio Zequi S BJU Int; 2014 May; 113(5b):E157-63. PubMed ID: 24053427 [TBL] [Abstract][Full Text] [Related]
4. WWOX protein expression varies among RCC histotypes and downregulation of WWOX protein correlates with less-favorable prognosis in clear RCC. Lin JT; Tzai TS; Liao CY; Wang JS; Wu TT; Wang HY; Wu CH; Yu CC; Lu PJ Ann Surg Oncol; 2013 Jan; 20(1):193-9. PubMed ID: 22555346 [TBL] [Abstract][Full Text] [Related]
5. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma. Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583 [TBL] [Abstract][Full Text] [Related]
6. Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues. Liu X; Cao L; Ni J; Liu N; Zhao X; Wang Y; Zhu L; Wang L; Wang J; Yue Y; Cai Y; Jin J Int J Oncol; 2013 Dec; 43(6):1925-34. PubMed ID: 24101097 [TBL] [Abstract][Full Text] [Related]
7. Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer. Michels J; Adam J; Goubar A; Obrist F; Damotte D; Robin A; Alifano M; Vitale I; Olaussen KA; Girard P; Cremer I; Castedo M; Soria JC; Kroemer G Ann Oncol; 2015 Dec; 26(12):2470-7. PubMed ID: 26387143 [TBL] [Abstract][Full Text] [Related]
8. Roles of DNA damage repair and precise targeted therapy in renal cancer (Review). Lai Y; Li Z; Lu Z; Zheng H; Chen C; Liu C; Yang Y; Tang F; He Z Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36263616 [TBL] [Abstract][Full Text] [Related]
9. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs. Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825 [TBL] [Abstract][Full Text] [Related]
10. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma. Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosis. Buchner A; Castro M; Hennig A; Popp T; Assmann G; Stief CG; Zimmermann W Urology; 2010 Aug; 76(2):507.e6-11. PubMed ID: 20538322 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance. Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731 [TBL] [Abstract][Full Text] [Related]
13. [Expressions of EZH2 and RUNX3 in renal cell carcinoma and their clinical significance]. Wang G; Qin W; Zheng J; Wei M; Zhou X; Wang H; Wen W Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):82-4, 88. PubMed ID: 23294722 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of arginine ADP-ribosyltransferase 1 reduces the expression of poly(ADP-ribose) polymerase-1 in colon carcinoma. Tang Y; Wang YL; Yang L; Xu JX; Xiong W; Xiao M; Li M Int J Mol Med; 2013 Jul; 32(1):130-6. PubMed ID: 23652727 [TBL] [Abstract][Full Text] [Related]
15. Poly(adenosine diphosphate-ribose) polymerase expression in BRCA-proficient ovarian high-grade serous carcinoma; association with patient survival. Gan A; Green AR; Nolan CC; Martin S; Deen S Hum Pathol; 2013 Aug; 44(8):1638-47. PubMed ID: 23574784 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance and therapeutic potential of prostate cancer antigen-1/ALKBH3 in human renal cell carcinoma. Hotta K; Sho M; Fujimoto K; Shimada K; Yamato I; Anai S; Harada H; Tsujikawa K; Konishi N; Shinohara N; Nakajima Y Oncol Rep; 2015 Aug; 34(2):648-54. PubMed ID: 26035443 [TBL] [Abstract][Full Text] [Related]
18. Studies of the expression of human poly(ADP-ribose) polymerase-1 in Saccharomyces cerevisiae and identification of PARP-1 substrates by yeast proteome microarray screening. Tao Z; Gao P; Liu HW Biochemistry; 2009 Dec; 48(49):11745-54. PubMed ID: 19877712 [TBL] [Abstract][Full Text] [Related]
19. Expression of human poly (ADP-ribose) polymerase 1 in Saccharomyces cerevisiae: Effect on survival, homologous recombination and identification of genes involved in intracellular localization. La Ferla M; Mercatanti A; Rocchi G; Lodovichi S; Cervelli T; Pignata L; Caligo MA; Galli A Mutat Res; 2015 Apr; 774():14-24. PubMed ID: 25779917 [TBL] [Abstract][Full Text] [Related]
20. Analysis of poly(ADP-ribose) polymerase-1 (PARP1) gene alteration in human germ cell tumor cell lines. Ogino H; Nakayama R; Sakamoto H; Yoshida T; Sugimura T; Masutani M Cancer Genet Cytogenet; 2010 Feb; 197(1):8-15. PubMed ID: 20113831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]